Home / Companies / Nuvectis Pharma, Inc. / 13 Jun 2024
Nuvectis Pharma, Inc.: meeting of 13 Jun 2024
Votes reported on Form N-PX, item by item
37 Form N-PX filers reported votes at the Nuvectis Pharma, Inc. meeting of 13 Jun 2024. Their records fall into 2 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
2 nominees; 18.0% of reported votes for; 36 filers withheld from or voted against at least one nominee.
124 vote records from 37 filers. 24 of the 36 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
62 vote records from 37 filers. 0 of the 36 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
How the largest families voted
| Family | 1. Directors | 2. Auditor |
|---|---|---|
| Vanguard | Split or no vote | For |
| BlackRock and iShares | Split or no vote | For |
| Fidelity | Against * | For |
| State Street and SPDR | Against * | For |
| Equitable | Against * | For |
| Charles Schwab | Split or no vote | For |
| Nuveen and TIAA | Against * | For |
| ProShares and ProFunds | Against * | For |
| John Hancock and Manulife | Against * | For |
| Morgan Stanley, Eaton Vance and Calvert | Against * | For |
| T. Rowe Price | Against * | For |
| Lincoln Financial | Against * | For |
| Nationwide | Against * | For |
| Victory Capital | Against * | For |
| Guggenheim and Rydex | Against * | For |
| Principal | Against * | For |
| Pacific Life funds | Split or no vote | For |
| Global X | Split or no vote | For |
| DWS | Against * | For |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Nuvectis Pharma, Inc. meeting?
37 Form N-PX filers reported votes at the meeting of 13 Jun 2024. The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Nuvectis Pharma, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Nuvectis Pharma, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Nuvectis Pharma, Inc. with a meeting date within three days of 13 Jun 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.